INOZYME PHARMA INC

CUSIP: 45790W108 Class: Common Stock

Rock Springs Capital Management LP's Holding History (CIK: 0001595725)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 3,445,299 Value ($000) $3,135 Avg Close Range
Q4 2024
Shares 3,861,983 Value ($000) $10,698 Avg Close Range
Q3 2024
Shares 3,802,883 Value ($000) $19,889 Avg Close Range
Q2 2024
Shares 3,698,374 Value ($000) $16,495 Avg Close Range
Q1 2024
Shares 3,681,174 Value ($000) $28,198 Avg Close Range
Q4 2023
Shares 3,681,174 Value ($000) $15,682 Avg Close Range
Q3 2023
Shares 3,681,174 Value ($000) $15,461 Avg Close Range
Q2 2023
Shares 3,428,084 Value ($000) $19,094 Avg Close Range
Q1 2023
Shares 3,214,900 Value ($000) $18,421 Avg Close Range
Q4 2022
Shares 3,086,027 Value ($000) $3,240 Avg Close Range
Q3 2022
Shares 2,807,618 Value ($000) $7,524 Avg Close Range
Q2 2022
Shares 2,640,056 Value ($000) $12,593 Avg Close Range
Q1 2022
Shares 1,193,195 Value ($000) $4,880 Avg Close Range
Q4 2021
Shares 868,466 Value ($000) $5,923 Avg Close Range
Q3 2021
Shares 850,015 Value ($000) $9,852 Avg Close Range
Q2 2021
Shares 840,272 Value ($000) $14,318 Avg Close Range
Q1 2021
Shares 827,900 Value ($000) $16,392 Avg Close Range
Q4 2020
Shares 830,546 Value ($000) $17,142 Avg Close Range
Q3 2020
Shares 879,954 Value ($000) $23,134 Avg Close Range